Organic compounds -- part of the class 532-570 series – Organic compounds – Cyclopentanohydrophenanthrene ring system containing
Reexamination Certificate
2006-02-07
2006-02-07
Qazi, Sabiha (Department: 1616)
Organic compounds -- part of the class 532-570 series
Organic compounds
Cyclopentanohydrophenanthrene ring system containing
C552S518000, C552S519000, C552S522000, C552S625000, C552S626000, C552S627000, C514S182000
Reexamination Certificate
active
06995278
ABSTRACT:
Compositions and methods for treating mammalian disease characterized by undesirable angiogenesis by administering derivatives of 2-methoxyestradiol of the general formula:wherein the variables are defined in the specification.
REFERENCES:
patent: 2584271 (1952-02-01), Huffman
patent: 2846453 (1958-08-01), Hoehn
patent: 3166577 (1965-01-01), Ringold et al.
patent: 3410879 (1968-11-01), Smith et al.
patent: 3470218 (1969-09-01), Farah
patent: 3492321 (1970-01-01), Crabbe
patent: 3496272 (1970-02-01), Kruger
patent: 3562260 (1971-02-01), De Ruggieri et al.
patent: 3956348 (1976-05-01), Hilscher
patent: 4172132 (1979-10-01), Draper et al.
patent: 4212864 (1980-07-01), Tax
patent: 4307086 (1981-12-01), Tax
patent: 4444767 (1984-04-01), Torelli et al.
patent: 4522758 (1985-06-01), Ward et al.
patent: 4634705 (1987-01-01), DeBernardis et al.
patent: 4743597 (1988-05-01), Javitt et al.
patent: 4994443 (1991-02-01), Folkman et al.
patent: 5001116 (1991-03-01), Folkman et al.
patent: 5135919 (1992-08-01), Folkman et al.
patent: 5504074 (1996-04-01), D'Amato et al.
patent: 5521168 (1996-05-01), Clark
patent: 5621124 (1997-04-01), Seilz et al.
patent: 5643900 (1997-07-01), Fotsis et al.
patent: 5661143 (1997-08-01), D'Amato et al.
patent: 5892069 (1999-04-01), D'Amato et al.
patent: 5958892 (1999-09-01), Mukhopadhyay et al.
patent: 6011023 (2000-01-01), Clark et al.
patent: 6051726 (2000-04-01), Sachdeva et al.
patent: 6054598 (2000-04-01), Sachdeva et al.
patent: 6136992 (2000-10-01), Ram et al.
patent: 6200966 (2001-03-01), Stewart
patent: 6239123 (2001-05-01), Green et al.
patent: 6448419 (2002-09-01), Paaren et al.
patent: 6730665 (2004-05-01), Maran et al.
patent: 2002/0035098 (2002-03-01), Slaga et al.
patent: 2003/0027803 (2003-02-01), Slaga et al.
patent: 2003/0036539 (2003-02-01), Slaga et al.
patent: 2003/0073674 (2003-04-01), Slaga et al.
patent: 2004/0053906 (2004-03-01), Slaga et al.
patent: 2339368 (2000-02-01), None
patent: 2385096 (2001-04-01), None
patent: 1907330 (1969-10-01), None
patent: 2 004 516 (1970-09-01), None
patent: 3625315 (1998-01-01), None
patent: 587081 (1960-12-01), None
patent: 857080 (1960-12-01), None
patent: 1570597 (1980-07-01), None
patent: 39-5480 (1964-04-01), None
patent: 41 000100 (1966-01-01), None
patent: 42-928 (1967-01-01), None
patent: 63090763 (1988-04-01), None
patent: 11-209322 (1999-08-01), None
patent: 1240038 (1996-10-01), None
patent: WO 87/02367 (1987-04-01), None
patent: WO 88/08002 (1988-10-01), None
patent: WO 90/15816 (1990-12-01), None
patent: WO 93/03729 (1993-03-01), None
patent: WO 95/04535 (1995-02-01), None
patent: WO 98/32763 (1998-07-01), None
patent: WO 98/40398 (1998-09-01), None
patent: WO 99/01142 (1999-01-01), None
patent: WO 99/33858 (1999-07-01), None
patent: WO 99/33859 (1999-07-01), None
patent: WO 00/07576 (2000-02-01), None
patent: WO 00/10552 (2000-03-01), None
patent: WO 00/66095 (2000-11-01), None
patent: WO 00/68246 (2000-11-01), None
patent: WO 01/27132 (2001-04-01), None
patent: WO 01/85755 (2001-11-01), None
Nambara et al. (DN 82:43650, CAPLUS, abstract of Chem.Pharm. Bull. (1974), 22(10), 2455-7).
Brueggemeier et al. (J. Med. Chem. (1996), 39, 1917-1923).
Pert et al. (DN 111:233338, CAPLUS, abstract of Australian J. of Chem. (1989), 42(3), 421-32).
Li et al. (DN 103:65176, CAPLUS, abstract of Molecular Pharmacology (1985), 27(5), 559-65).
Lilopristone/(1-[4-Dimethylamino)phenyl]-17-hydroxy-17-(3-hydroxy-1-propenyl)estra-4,9-diene-3-one; AK 98734Dict. of Drugs(1990),Dict. of Steroids(1991),Dict. of Org. Cmpds(6th Ed) (1996),Dict. of Pharm. Agents(1997), Title: Lilopristone/1-4[4-(Dimethylamino)phenyl]-17-hydroxy-17-(3-hydroxy-1-propenyl) estra-4,9-diene-3-one; AK 98734.
The Merck Index 11th Edition, (paragraphs 583-584), pp. 88, 1989.
Journal of Endocrinology, Steroidal regulation of oestradiol-17B dehydrogenase activity of the human breast cancer cell line MCF-7, vol./Iss: 188(1), pp.: 149-154, Jul. 1988.
Cancer Research, Natural Estrogens Induce Modulation of Microtubules in Chinese Hamster V79 Cells in Culture, vol./Iss: 55, pp. 1863-1868, May 1, 1995.
Attalia et al., 2-Methoxyestradiol Arrests Cells in Mitosis without Depolarizing Tubulin,Biochemical and Biophysical Research Communications, vol./Iss: 228, pp. 467-473, 1996.
Ayala et al., The Induction of Accelerated Thymic Programmed Cell Death During Polymicrobial Sepsis: Control by Corticosteroids but not Tumor Necrosis Factor (Abstract only), vol./Iss: 3 (4), pp. 259-267, Apr. 1995.
Banik et al., Orally Active Long-Acting Estrogen (3-(2-propynyloxy)-estra-1,3,5, (10)-triene-17.beta.-ol trimethylacetate),Steroids, vol./Iss: 16 (3), pp. 289-296, 1970.
Bardon et al., Steroid Receptor-Mediated Cytotoxicity of an Antiestrogen and and Antiprogestin in Breast Cancer Cells (Abstract only),Cancer Research, vol./Iss: 47 (5), pp. 1441-1448, Mar. 1, 1987.
Bhat et al., Estradiol-induced Mitotic Inhibition in the Bursa of Fabricius of Male Domestic Duckling,Mikroskopie, vol./Iss: 39, pp. 113-117, May 1982.
Blagosklonny et al., Raf-1/bcl-2 Phosphorylation: A Step from Microtubule Damabe to Cell Death,Cancer Research, vol./Iss: 57, pp. 130-135, Jan. 1, 1997.
Blickenstaff et al., Estrogen-Catharanthus (Vinca) Alkaloid Conjugates,Cytotoxic Estrogens in Hormone Receptive Tumors, pp. 89-105, 1980.
Boye et al., 185. Deaminocolchinyl Methyl Ether. Synthesis from 2,3,4,4′-Tetramaehoxybiphenyl-2-carbaldehyde. Comparison of Antitubulin Effects of,Helvetica Chimica Acta, vol./Iss: 72, pp. 1690-1696, 1989.
Brodie, A.M., Aromatase Inhibitors in the Treatment of Breast Cancer (Abstract only),Journal of Steroid Biochemistry and Molecular Biology, vol./Iss: 49 (4-6), pp. 281-287, Jun. 1994.
Brosens et al., Comparative Study of the Estrogenic Effect of Ethinylestradiol and Mestranol on the Endometrium,Laboratory for Gynecological Physiopatholog, vol./Iss: 14 (6), pp. 679-685, Dec. 1, 1976.
Castagnetta, L. et al., Simple Approach to Measure Metabolic Pathyways of Steroids in Living Cells,Journal of Chromatography, vol./Iss: 572, pp. 25-39, Dec. 6, 1991.
Chasserot-Golaz et al., Biotransformation of 17.beta.-hydroxy-11.beta.-(4-dimethylaminophenyl)17.alpha.1-propynl-estra-4,9-diene-3-one (RU486) in Rat Hepatoma Variants (Identifier only),Biochemical Pharmacology, vol./Iss: 46 (11), pp. 2100-2103, Jan. 1, 1993.
Chen et al., A New Synthetic Route to 2- and 4-Methoxyestradiols by Nucleophilic Substitution,Steroids, vol./Iss: 47 (1), pp. 63-66, Jan. 1986.
Chen et al., Synthesis of 11.beta.-(4-dimethyiaminophenyl)-17.beta-hydroxy-17.alpha.-(1-propyl) estra-4, 9-dien-3-one (RU486) (Identifier only),Nanjing Yaoxueyuan Xuebao, vol./Iss: 17 (4), pp. 282-285, 1986.
Cohen et al., Novel Total Synthesis of (+)-Estrone 3-Methyl Ether, (+)-13B-Ethyl-3-methoxygona-1,3,5(10-triene-17-one, and (+)-Equilenin 3-Methyl Ether,The Journal of Organic Chemistry, vol./Iss: 6, pp. 681-685, Mar. 21, 1975.
Collins et al., The Structure and Function of Estrogens. XI* Synthesis of (+/-)-7(8-11 α) abeo-Estradiol and its 9,11-Didehydro Derivative,Aust. Journal of Chemistry, vol./Iss: 45, pp. 71-97, 1992.
Crum, R. et al., A New Class of Steroids Inhibits Angiogenesis in the Presence of Heparin or a Heparin Fragment,Science, vol./Iss: 230, pp. 1375-1378, Dec. 20, 1985.
Cummings et al., Apoptosis,The American Journal of Surgical Pathology, vol./Iss: 21 (1), pp. 88-101, 1997.
Cushman et al., Synthesis, Antitubulin and Antimitotic Activity, and Cytotoxicity of Analogs of 2-Methoxyestradiol, an Endogenous Mammalian Metabolite of Estradiol that,Journal of Medical Chemistry, vol./Iss: 38 (12), pp. 2041-2049, 1995.
Cushman et al., Synthesis of Analogs of 2-Methoxyestradiol with Enhanced inhibitory Effects of Tubulin Polymerization and Cancer Cell Growth,Journal of Medical Chemistry, vol./Iss: 40 (15), pp. 2323-2334, 1997.
D'Amato et al., 2-Methoxyestradiol, an Endogenous Mammalian Metabolite, Inhibits Tubulin Polymerization by Interacting at the Colchicine Site,Proceedings of the National Academy of Science USA, vol./Iss: 91, pp. 3964-3968, Apr. 1994.
Dvir et al., Thin-layer Chromatography of DANSYL-oestroge
Agoston Gregory E.
Green Shawn J.
Pribluda Victor
Treston Anthony M.
Entre Med, Inc.
Kilpatrick & Stockton LLP
Qazi Sabiha
LandOfFree
Antiangiogenic agents does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Antiangiogenic agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antiangiogenic agents will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3651935